Therapeutic potential of biogenic silver nanoparticles in murine cutaneous leishmaniasis

Journal of Nano Research

Volumn 20, Issue , 2012, Pages 89-97

  Rossi Bergmann, Bartira ^a   Pacienza Lima, Wallace ^b   Marcato, Priscyla D ^b   De Conti, Roseli ^b   Durán, Nelson ^b,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Biogenic; In vivo; Leaishmaniasis; Silver nanoparticles

Indexed keywords

AMPHOTERICIN B; ANTI-MICROBIAL AGENT; BIOGENIC; BODY WEIGHT; CHEMICAL SYNTHESIS; FUSARIUM OXYSPORUMS; HEPATOTOXICITY; IN-VITRO; IN-VIVO; LEAISHMANIASIS; LEISHMANIA; NEPHROTOXICITY; PROMASTIGOTES; SERUM LEVELS; SILVER NANOPARTICLES; THERAPEUTIC POTENTIALS;

BIOCHEMISTRY; DRUG DOSAGE; NANOPARTICLES; SYNTHESIS (CHEMICAL);

SILVER;

EID: 84871838810     PISSN: 16625250     EISSN: 16619897     Source Type: Journal    
DOI: 10.4028/www.scientific.net/JNanoR.20.89     Document Type: Article

References (25)

1. J. Alvar, I.D. Vélez, C. Bern, M. Herrero, P. Desjeux, J. Cano, J. Jannin, M. Boer, The WHO Leishmaniasis Control Team, Leishmaniasis. Worldwide and global estimates of its incidence, Plos One. 7 (2012) e35671.
2. T. Garnier, S.L. Croft, Topical treatment for cutaneous leishmaniasis, Curr Opin Investig Drugs. 3 (2002) 538-544.
3. A.M. Alkhawajah, E. Larbi, Y. al-Gindan, A. Abahussein, S. Jain, Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration, Ann Trop Med Parasitol. 91 (1997) 899-905. (Pubitemid 28019791)
4. I. Esfandiarpour, S. Farajzadeh, Z. Rahnama, E. A. Fathabadi, A. Heshmatkhah, Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis, International Journal of Dermatology. 10 (2012) 1121-122.
5. M. Navarro, E. J. Cisneros-Fajardo and E. Marchan, New silver polypyridyl complexes: synthesis, characterization, and biological activity on Leishmania Mexicana, Arzn. Forsch. 56 (2006) 600-604. (Pubitemid 44358652)
6. A.B. Seabra, and N. Durán, Nitric oxide-releasing vehicles for biomedical applications, Journal of Materials Chemistry. 20 (2010) 1624-1637.
7. E.C. Torres-Santos, M.I. Sampaio-Santos, F.S. Buckner, K. Yokoyama, M. Gelb, J. A. Urbina, B. Rossi-Bergmann, Altered sterol profile induced in Leishmania amazonensis by a natural dihydroxymethoxylated chalcone, J. Antimicrob. Chemother. 63 (2009) 469-472.
8. I. Arevalo, B. Ward, R. Miller, T.C. Meng, E. Najar, E. Alvarez, G. Matlashewski, A. Llanos-Cuentas, Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator, Clinical Infectious Diseases. 33 (2001) 1847-1851. (Pubitemid 33105123)
9. A.M. Allahverdiyev, S.A. Emrah, M. Bagirova, C.B. Ustundag, C. Kaya, F. Kaya, and M. Rafailovich, Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light, Int J Nanomedicine. 6 (2011) 2705-2714.
10. P.D. Marcato, R. De Conti, B. Rossi-Bergmann and N. Durán, Silver nanoparticles/clindamycin: antileishmanial activity VII Ann. Meeting of SBPMat, (2008) September 28-October 2, Guarujá-SP, Brasil.
11. P. Mohanpuria, P.N.K. Rana, and S.K. Yadav, Biosynthesis of nanoparticles: technological concepts and future applications J. Nanopart. Res. 10 (2008) 507-517.
12. V.K. Sharma, R.A. Yngard, and Y. Lin, Silver nanoparticles: Green synthesis and their antimicrobial activities Advan. Colloid Interf. Sci. 145 (2009) 83-96.
13. V. Deepak, P.S. Umamaheshwaran, K. Guhan, R.A. Nanthini, B. Krithiga, N.M.H. Jaithoon, S. Gurunathan, Synthesis of gold and silver nanoparticles using purified. Collids and Surfaces B-Biointerfaces, 86 (2011) 353-358.
14. N. Durán, P.D. Marcato, M. Durán, A. Yadav, A. Gade, M. Rai, Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants. Applied Microbiology and Biotechnology. 90 (2011) 1609-1624.
15. G.P. Pei, L.S.F.Y. Yau, Potential of plant as a biological factory to synthesize gold and silver nanoparticles and their applications, Reviws in Environmental Science and Bio-technology. 11 (2012) 169-206.
16. T.N.V.K.V. Prasad, V.S.R. Kambala, R. Naidu, A Critical Review on Biogenic Silver Nanoparticles and their Antimicrobial Activity. Current Nanoscience. 4 (2011) 531-544.
17. N. Durán, P.D. Marcato, O.L. Alves, H.I.H. De Souza, and E. Esposito, Mechanistic aspects of biosyntheis of silver nanoparticles by several Fusarium oxysporum strains. J. Nanobiotechnol. 3 (2005) 1-7.
18. N. Durán, P.D. Marcato, H.I.H. De Souza, O.L. Alves, and E. Esposito, Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J. Biomed. Nanotechnol. 3 (2007) 203-208. (Pubitemid 351877171)
19. M. Mohebali, M.M. Rezayat, K. Gilani, S. Sarkar, B. Akhoundi, J. Esmaeili, T. Satvat, S. Elikaee, S. Charehdar, H. Hooshyar, Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study. DARU. 17 (2009) 285-289.
20. A.M. Allahverdiyev, E.S. Abamor, M. Bagirova, C.B. Ustundag, C. Kaya, F. Kaya, M. Rafailovich, Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. International Journal of Nanomedicine. 6 (2011) 2705-2714.
21. B. Rossi-Bergmann, C.A.B. Falcão, A. Lenglet, C.R. Bezerra-Santos, D. Costa-Pinto and Y.M. Traub-Czeko, A simple fluorimetric method for assessing drug and vaccine efficacy in cutaneous leishmaniasis using Leishmania amazonensis expressing green fluorescence protenin Mem. I. Oswaldo Cruz (Suppl. II), 94 (1999) 70-74.
22. F.C. Silva Filho, E.M. Saraiva, M.A. Santos, W. de Souza, The surface free energy of Leishmania mexicana amazonensis. Cell Biophys. 2 (1990) 137-51.
23. S.L. Croft, and G.H. Coombs, Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends in Parasitology. 19 (2003) 502-508. (Pubitemid 37329659)
24. F.J. Abajo and A.J. Carcas Amphotericin-B Hepatotoxicity. British Medical Jounal. 293 (1986) 1243-1243.
25. I. Karimzadeh, S. Farsaei, H. Khalili, S. Dashti-Khavidaki, Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity Expert Opinion on Drug Safety. 11 (2012) 969-983.